Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web


  Free Subscription


2 Arch Virol
1 Clin Infect Dis
2 Dig Dis Sci
4 Eur J Gastroenterol Hepatol
1 Gastroenterology
2 Gut
2 Hepatology
3 J Hepatol
1 J Med Virol
1 J Viral Hepat
4 J Virol
1 Pediatr Infect Dis J
1 PLoS One
2 PLoS Pathog
1 Virology

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Arch Virol

  1. TANG WF, Kong DG, Wang YH, Liu MQ, et al
    Hepatitis E virus infection in Wuhan, Central China.
    Arch Virol. 2018 Sep 18. pii: 10.1007/s00705-018-4036.
    PubMed     Text format     Abstract available

  2. MIRAZO S, D Albora C, Quintero Gil D, Cabrera K, et al
    A case of incidental infection of Hepatitis E virus (HEV) genotype 1 in a domestic pig.
    Arch Virol. 2018 Sep 15. pii: 10.1007/s00705-018-4025.
    PubMed     Text format     Abstract available

    Clin Infect Dis

  3. PATEL EU, Mehta SH, Boon D, Quinn TC, et al
    Limited Coverage of Hepatitis C Virus Testing in the United States, 2013-2017.
    Clin Infect Dis. 2018 Sep 15. pii: 5098442. doi: 10.1093.
    PubMed     Text format     Abstract available

    Dig Dis Sci

  4. LEE HM, Ahn J, Kim WR, Lim JK, et al
    A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Results of the ENUMERATE Study.
    Dig Dis Sci. 2018 Sep 20. pii: 10.1007/s10620-018-5281.
    PubMed     Text format     Abstract available

  5. SHERMAN KE, Rouster SD, Kang M, Umbleja T, et al
    PNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected Individuals.
    Dig Dis Sci. 2018 Sep 14. pii: 10.1007/s10620-018-5278.
    PubMed     Text format     Abstract available

    Eur J Gastroenterol Hepatol

  6. POYNARD T, Munteanu M, Charlotte F, Perazzo H, et al
    Impact of steatosis and inflammation definitions on the performance of NASH tests.
    Eur J Gastroenterol Hepatol. 2018;30:384-391.
    PubMed     Text format     Abstract available

  7. TONON M, Piano S, Romano A, Fasolato S, et al
    Assessment of bone mineral density in patients with cirrhosis treated with third-generation nucleos(t)ide analogues: comparison between tenofovir and entecavir.
    Eur J Gastroenterol Hepatol. 2018;30:284-290.
    PubMed     Text format     Abstract available

  8. PONZETTO A, Figura N
    Helicobacter pylori infection among patients with liver cirrhosis.
    Eur J Gastroenterol Hepatol. 2018;30:490.
    PubMed     Text format    

  9. ATTIA D, Deterding K, Cornberg J, Gebel MJ, et al
    Different kinetics of liver stiffness using shear wave elastography in patients with chronic hepatitis C infection treated with interferon-free regimens.
    Eur J Gastroenterol Hepatol. 2018 Sep 19. doi: 10.1097/MEG.0000000000001259.
    PubMed     Text format     Abstract available


  10. VYAS AK, Jindal A, Trehanpati N
    Ponder the Innate Immunity in Hepatitis B Infection.
    Gastroenterology. 2018 Sep 14. pii: S0016-5085(18)34759.
    PubMed     Text format    


  11. CHEN HY, Shen DT, Ji DZ, Han PC, et al
    Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis.
    Gut. 2018 Sep 18. pii: gutjnl-2018-316601. doi: 10.1136/gutjnl-2018-316601.
    PubMed     Text format     Abstract available

  12. YIGIT B, Boyle M, Ozler O, Erden N, et al
    Plasma cell-free DNA methylation: a liquid biomarker of hepatic fibrosis.
    Gut. 2018 Jan 20. pii: gutjnl-2017-315668. doi: 10.1136/gutjnl-2017-315668.
    PubMed     Text format    


  13. ANASTASIOU OE, Widera M, Westhaus S, Timmer L, et al
    Clinical outcome and viral genome variability of hepatitis B virus induced acute liver failure (HEP-18-0579).
    Hepatology. 2018 Sep 19. doi: 10.1002/hep.30279.
    PubMed     Text format     Abstract available

  14. SONG ATW, Abdala E, de Martino RB, Malbouisson LMS, et al
    Liver transplantation for fulminant hepatitis due to yellow fever.
    Hepatology. 2018 Sep 15. doi: 10.1002/hep.30273.
    PubMed     Text format     Abstract available

    J Hepatol

  15. DEUFFIC-BURBAN S, Huneau A, Verleene A, Brouard C, et al
    Assessing the cost-effectiveness of hepatitis C screening strategies in France.
    J Hepatol. 2018;69:785-792.
    PubMed     Text format     Abstract available

  16. BERENGUER M, de la Rosa Rodriguez G, Dominguez-Gil B
    Significant impact of new oral therapies against HCV on the waiting list for liver transplantation in Spain.
    J Hepatol. 2018;69:966-968.
    PubMed     Text format    

  17. NEWSUM AM, Molenkamp R, van der Meer JT, Rebers SP, et al
    Persistence of NS5B-S282T, a sofosbuvir resistance-associated substitution, in a HIV/HCV-coinfected MSM with risk of onward transmission.
    J Hepatol. 2018;69:968-970.
    PubMed     Text format    

    J Med Virol

  18. WAHID B, Waqar M, Rasool N, Wasim M, et al
    Prevalence of TSH dysfunction among sofosbuvir-treated HCV infected patients: a real-world clinical experience.
    J Med Virol. 2018 Sep 19. doi: 10.1002/jmv.25319.
    PubMed     Text format     Abstract available

    J Viral Hepat

  19. LIU Z, Chen X, Zhang T
    Reply to "The epidemiology of hepatitis B virus infection in China".
    J Viral Hepat. 2018 Sep 21. doi: 10.1111/jvh.13007.
    PubMed     Text format     Abstract available

    J Virol

  20. DOMINGUEZ-MOLINA B, Machmach K, Perales C, Tarancon-Diez L, et al
    Toll Like Receptor-7 and -9 agonists improve Hepatitis C Virus replication and infectivity inhibition by plasmacytoid dendritic cells.
    J Virol. 2018 Sep 19. pii: JVI.01219-18. doi: 10.1128/JVI.01219.
    PubMed     Text format     Abstract available

  21. QIAO L, Sui J, Luo G
    Robust human and murine hepatocyte culture models of hepatitis B virus infection and replication.
    J Virol. 2018 Sep 19. pii: JVI.01255-18. doi: 10.1128/JVI.01255.
    PubMed     Text format     Abstract available

  22. QU B, Ni Y, Lempp FA, Vondran FWR, et al
    T5 exonuclease hydrolysis of Hepatitis B Virus replicative intermediates allows reliable quantification and fast drug efficacy testing of covalently closed circular DNA by PCR.
    J Virol. 2018 Sep 19. pii: JVI.01117-18. doi: 10.1128/JVI.01117.
    PubMed     Text format     Abstract available

  23. GONZALEZ-LOPEZ O, Rivera-Serrano EE, Hu F, Hensley L, et al
    Redundant late domain functions of tandem VP2 YPX3L motifs in nonlytic cellular egress of quasi-enveloped hepatitis A virus.
    J Virol. 2018 Sep 19. pii: JVI.01308-18. doi: 10.1128/JVI.01308.
    PubMed     Text format     Abstract available

    Pediatr Infect Dis J

  24. FOUAD H, Mohamed A, Sabry M, Abdel Aziz H, et al
    The Effectiveness of Ledipasvir/Sofosbuvir in Youth with Genotype 4 Hepatitis C Virus; A Single Egyptian Center Study.
    Pediatr Infect Dis J. 2018 Sep 18. doi: 10.1097/INF.0000000000002189.
    PubMed     Text format     Abstract available

    PLoS One

  25. DAS S, Opoku J, Allston A, Kharfen M, et al
    Detecting spatial clusters of HIV and hepatitis coinfections.
    PLoS One. 2018;13:e0203674.
    PubMed     Text format     Abstract available

    PLoS Pathog

  26. MINGORANCE L, Castro V, Avila-Perez G, Calvo G, et al
    Host phosphatidic acid phosphatase lipin1 is rate limiting for functional hepatitis C virus replicase complex formation.
    PLoS Pathog. 2018;14:e1007284.
    PubMed     Text format     Abstract available

  27. ROSENBERG BR, Depla M, Freije CA, Gaucher D, et al
    Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance.
    PLoS Pathog. 2018;14:e1007290.
    PubMed     Text format     Abstract available


  28. TSUGE M, Hiraga N, Zhang Y, Yamashita M, et al
    Endoplasmic reticulum-mediated induction of interleukin-8 occurs by hepatitis B virus infection and contributes to suppression of interferon responsiveness in human hepatocytes.
    Virology. 2018;525:48-61.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.